Press Release | January 8, 2020
Entrada Therapeutics Announces ENTR-501 for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)
Read More
Press Release | January 6, 2020
Carisma Therapeutics Expands Leadership Team
Read More
